Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Sarcoma × 5-imino-13-deoxydoxorubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Advanced Solid Tumors - Phase 1 Population 1

Interventions

Doxorubicin 30 pembrolizumab 12 Gemcitabine 11 Irinotecan 9 pazopanib 8 eribulin 8 Trabectedin 8 olaratumab 7 Cyclophosphamide 6 anlotinib 5 Injections 5 Docetaxel 5 ridaforolimus 4 Temozolomide 4 Nivolumab 4 Ifosfamide 4 Fluorouracil 4 Carboplatin 4 Bevacizumab 4 tazemetostat 3 belinostat 3 TH 302 3 Paclitaxel 3 Ipilimumab 3 Epirubicin 3 Drug Therapy 3 Dacarbazine 3 DOXO-EMCH 3 trastuzumab deruxtecan 2 toripalimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02267083 2018-01-10

Efficacy and Safety Study of GPX-150 to Treat Soft Tissue Sarcoma

Gem Pharmaceuticals

Phase 2 Completed

22 enrolled 10 charts

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡